NCT04006288 Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Status COMPLETED Phase PHASE4
NCT03961334 MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention Status RECRUITING Phase PHASE3
NCT03907046 Anticoagulation in ICH Survivors for Stroke Prevention and Recovery Status RECRUITING Phase PHASE3
NCT03869268 The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin Status COMPLETED Phase PHASE4
NCT03820466 Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin Status TERMINATED Phase PHASE3
NCT03805932 Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03796156 Aspirin to Target Arterial Events in Chronic Kidney Disease Status TERMINATED Phase PHASE3
NCT03794596 A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer Status WITHDRAWN Phase PHASE2
NCT03794336 Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive Status COMPLETED Phase PHASE4
NCT03787927 Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets Status UNKNOWN Phase PHASE1/PHASE2
NCT03766581 A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel Status COMPLETED Phase PHASE2
NCT03698513 A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03620760 Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation Status UNKNOWN Phase PHASE4